---
title: "Applied Survival Analysis"
subtitle: "Chapter 10 - Competing/Semi-Competing Risks"
css: style_slides.css
author:
  name: Lu Mao
  affiliation: 
   - name: Department of Biostatistics & Medical Informatics
   - University of Wisconsin-Madison
  email: lmao@biostat.wisc.edu
format: 
  revealjs:
    auto-stretch: false
editor: visual
include-in-header:
  - text: |
      <style type="text/css">
      ul li ul li {
        font-size: 0.75em;
      }
      </style>
---

## Outline
:::{.incremental}
1.  Cause-specific hazard and cumulative incidence

2.  Non- and semi-parametric methods

3.  Analysis of bone marrow transplantation study

4.  Semi-competing risks and examples
:::

$$\newcommand{\d}{{\rm d}}$$ $$\newcommand{\T}{{\rm T}}$$ $$\newcommand{\dd}{{\rm d}}$$ $$\newcommand{\cc}{{\rm c}}$$ $$\newcommand{\pr}{{\rm pr}}$$ $$\newcommand{\var}{{\rm var}}$$ $$\newcommand{\se}{{\rm se}}$$ $$\newcommand{\indep}{\perp \!\!\! \perp}$$ $$\newcommand{\Pn}{n^{-1}\sum_{i=1}^n}$$

# Basic Quantities

## Definition and Examples
:::{.fragment}
-   **Competing risks**
    -   **Definition**: multiple types of failures, occurrence of one **precludes** others
        -   Multiple latent risks competing with each other for first occurrence
    -   **Examples**: different causes of death
:::
:::{.fragment}
-   **Defining feature**
    -   One failure per subject
    -   Less info than multivariate failure times
    -   Implications for analysis and interpretation
:::

## Outcome Data & Identifiability
:::{.fragment}
-   **Target of inference**: $(T, \Delta)$
    -   $T$: **time** to failure
    -   $\Delta \in \{1, \ldots, K\}$: **type/cause** of failure (categorical)
:::
:::{.fragment}
-   **Multivariate perspective**
    -   **A conceptual framework** \begin{equation}\label{eq:cmpr:mult}
        T=\min(T_1,\ldots, T_K) \hspace{1mm}\mbox{ and } \hspace{1mm}\Delta=\arg\min_{k=1,\ldots, K} T_k
        \end{equation}
        -   $T_k$: time to $k$th *latent* risk $(k=1,\ldots, K)$ in absence of other risks
        -   Competing risks $=$ partially observed multivariate failure times
    -   **Identifiability**: net distribution of latent $T_k$ not recognizable from $(T, \Delta)$
        -   unless under unrealistic assumption of mutual independence of the $T_k$
:::

## Two Approaches
:::{.fragment}
-   **Two ways** to characterize $(T, \Delta)$
    -   **Cause-specific hazard**
    -   **Cumulative incidence (Sub-distribution)**
:::
:::{.fragment}
-   **Cause-specific hazard (CSH)**
 \begin{equation}\label{eq:cmpr:cs_hazard}
        \dd\Lambda_k^\cc(t)=\pr(t\leq T<t+\dd t, \Delta=k\mid T\geq t)
        \end{equation}
    -   **Interpretation**: instantaneous incidence of $k$th risk given overall "survival"
    -   **Example**: $\dd\Lambda_1^\cc(t)=$ incidence rate for CV death among survivors at $t$
        -   $k =1$: CV death; $k =2$: other causes of death
    -   **Overall hazard**: $\dd\Lambda(t)=\pr(t\leq T<t+\dd t \mid T\geq t) = \sum_{k=1}^K \dd\Lambda_k^\cc(t)$
:::

## Cause-Specific Hazard
:::{.fragment}
-   **Limitations**
    -   The *cumulative* CSH $\Lambda_k^\cc(t)$ not a meaningful quantity
    -   $\exp\{-\Lambda_k^\cc(t)\}$ not a survival function of any kind
:::
:::{.fragment}
-   **Correspondence with "net hazard"**
    -   Under (unrealistic) mutual independence of the latent $T_k$
    -   Hazard of $T_k$ identifiable and equal to $\Lambda_k^\cc(t)$
    -   Not recommended
:::

## Cumulative Incidence
:::{.fragment}
-   **Cumulative incidence function (CIF)**
        $$
        F_k(t)=\pr(T\leq t, \Delta=k)
        $$
    -   **Interpretation**: probability of failure from $k$th risk *in presence of* other risks 
    -   Marginal quantity, easy to interpret (a real-world probability)
    -   $F(t)=\pr(T\leq t) = \sum_{k=1}^K F_k(t)$ (*sub*-distribution functions)
:::
:::{.fragment}
-   **Relationship**
    -   CSH in terms of CIF (for a particular risk, no one-to-one correspondence) \begin{equation}\label{eq:cmpr:correspond}
        \dd\Lambda_k^\cc(t)=\frac{\dd F_k(t)}{1-\sum_{l=1}^K F_l(t-)}
        \end{equation}
:::

## CSH vs CIF
:::{.fragment}
-   **Example**: effect on CSH may not align with CIF
    -   **Treatment**: $\Lambda_1^\cc(t)=\Lambda_2^\cc(t)=3t$
    -   **Control**: $\Lambda_1^\cc(t)=2t$ and $\Lambda_2^\cc(t)=t$
:::   
:::{.fragment}
![](images/cmpr_compare.png){fig-align="center" width="60%"}
::: 

## Comparison of Functions

-   **CSH vs net hazard vs CIF**

![](images/cmpr_functions.png){fig-align="center" width="90%"}

# Methods for Competing Risks

## Observed Data
:::{.incremental}
-   **A random** $n$-sample $$(X_i, \delta_i, Z_i), \,\,\, i=1,\ldots, n$$
    -   $X=T\wedge C$
    -   $\delta=\Delta I(T\leq C)$ (0: censored; $k$: observed $k$th risk, $k=1,\ldots, K$)
    -   $C$: independent censoring time
    -   $Z$: covariates
    -   $N_{ki}(t)=I(X_i\leq t, \delta_i=k)$: *Observed* counting process for $k$th risk 
::: 

## Cause-Specific Hazard Models (I)
:::{.fragment}
-   **Proportional cause-specific hazards** \begin{equation}\label{eq:cmpr:ph_csh}
    \pr(t\leq T<t+\dd t, \Delta=k\mid T\geq t, Z)=\exp(\beta_k^\T Z)\dd\Lambda_{k0}(t)
    \end{equation}
    -   A model on "survivors" (those who have not failed from any risk)
    -   $\beta_k$: log-hazard ratios for $k$th risk in survivors
::: 
:::{.fragment}
-   **Estimation** 
    -   **Partial likelihood score** for $k$th risk
    $$
      U_{nk}(\beta_k)=\Pn\int_0^\infty\left\{Z_i-\frac{\sum_{j=1}^n I(X_j\geq t)Z_j\exp(\beta_k^\T Z_j)}{\sum_{j=1}^n I(X_j\geq t)\exp(\beta_k^\T Z_j)}\right\}\dd N_{ki}(t)
    $$
        -   Essentially treating non-$k$ risks as censoring
        -   Easy to implement in `survival::coxph()` (`status == k`)
:::

## Cause-Specific Hazard Models (II)
:::{.fragment}
-   **Under (unrealistic) independence of the latent** $T_k$
    -   Proportional cause-specific hazards $\Longleftrightarrow$ proportional net hazards
    -   Frailty to relax independence
    -   Not recommended
        -   Non-identifiability
        -   Non-interpretability
:::
:::{.fragment}
-   **Log-rank test**
    -   Risk-specific log-rank statisic with other risks treated as censoring
    -   "Kaplan-Meier" doesn't work $\to$ estimand $\exp\{-\Lambda_k^\cc(t)\}$ is non-quantity
    -   Competing-risks equivalent of KM is Gray (1988) estimator of $F_k(t)$
:::

## CIF: Nonparametric Estimation
:::{.fragment}
-   **Decomposition of** $F_k(t)$
\begin{equation*}
        \dd F_k(t)=S(t-)\dd\Lambda_k^\cc(t)
\end{equation*}

    -   $S(t-)=\pr(T\geq t)$: By KM estimator $\hat S(t-)$ for overall failure

    -   $\dd\Lambda_k^\cc(t)$: By Nelsen-Aalen estimator (non-$k$ risks as censoring) $$
          \dd\hat\Lambda_k^\cc(t)=\frac{\sum_{i=1}^n\dd N_{ki}(t)}{\sum_{i=1}^n I(X_i\geq t)}
          $$
:::
:::{.fragment}
-   **Gray estimator** 
\begin{equation*}
        \hat F_k(t)=\int_0^t \hat S(u-)\dd\hat \Lambda_k^\cc(u)
\end{equation*}
:::

## CIF: Sub-Distribution Hazard
:::{.incremental}
-   **Sub-distribution hazard (SDH)**
\begin{equation}\label{eq:cmpr:sdh}
        \dd\Lambda_k(t)=\pr(t\leq T_k^*<t+\dd t\mid T_k^*\geq t)
        \end{equation}
    -   Time to $k$th risk *in presence of* other risks $$
        T_k^*=T\cdot I(\Delta=k)+\infty\cdot I(\Delta\neq k)
        $$
        -   $F_k(t)=\pr(T_k^*\leq t)$
    -   **Interpretation**: incidence of $k$th risk given not failing from it 
    -   Easier to work with hazard-like functions (unbounded)
    -   **Correspondence with CIF** \begin{equation}\label{eq:cmpr:subdist}
        F_k(t)=1-\exp\{-\Lambda_k(t)\}
        \end{equation}
    -   **Model/test on SDH** $\Longleftrightarrow$ Model/test on CIF
:::

## CIF: Gray's Test
:::{.fragment}
-   **Discrete version** ($k$th risk) $$
    \dd\Lambda_k(t)=\frac{\dd F_k(t)}{1-F_k(t-)}
    $$
:::
:::{.fragment}
-   **Log-rank-type test**
    -   Testing $H_0: F_{k1}(t)=F_{k0}(t)$ \begin{equation}\label{eq:cmpr:gray_tests}
        \int_0^\infty W_k(t)\big\{\dd\hat\Lambda_{k1}(t)-\dd\hat\Lambda_{k0}(t)\big\}
        \end{equation}
    -   $\hat\Lambda_{ka}(t)$: Gray's CIF plug-in estimator for SDH in group $a$ $(a=1, 0)$
    -   $W_k(t)$: Weight function
    -   **Extensions**: multi-group, stratification, etc.
:::

## CIF: Fine-Gray Regression
:::{.fragment}
-   **Proportional sub-distribution hazards** (Fine and Gray, 1999) \begin{equation}\label{eq:cmpr:fg}
 \pr(t\leq T_k^*<t+\dd t\mid T_k^*\geq t, Z)=\exp(\beta_k^\T Z)\dd\Lambda_{k0}(t)
  \end{equation}
    -   $\beta_k$: **log-hazard ratios** for $k$th risk in entire population (under other risks)
    -   **Estimation and inference**: partial-likelihood score with IPCW to address dependent censoring by other risks
:::
:::{.fragment}
-   **Target populations**
    -   **Cause-specific hazard**: survivors
    -   **Sub-distribution hazard**: all, including those who have failed from other causes
:::

## Software: `cmprk::cuminc()`
:::{.fragment}
-   **Basic syntax for Gray's estimator & test**

::: big-code
```{r}
#| eval: false
#| echo: true
obj <- cuminc(ftime, fstatus, group, strata, rho = 0)
```
:::

-   **Input**
    -   `(ftime, fstatus)`: $(X, \delta)$
    -   `group`: group variable (optional); `strata`: strata variable (optional)
    -   `rho`: $\rho$ in weight $W_k(t)=\{1 - \hat F_k(t)\}^\rho$ (HF $G^\rho$ family)
-   **Output**: a list
    -   `obj$Tests`: tests results on each risk
    -   `obj$"a k"`: CIF estimates for $k$th risk in group $a$
        -   `time`: $t$; `est`: $\hat F_k(t)$; `var`: $\hat\var\{\hat F_k(t)\}$
:::

## Software: `cmprk::crr()` (I)
:::{.fragment}
-   **Basic syntax for Fine-Gray model**

::: big-code
```{r}
#| eval: false
#| echo: true
obj <- crr(ftime, fstatus, cov1, failcode = k)
```
:::

-   **Input**
    -   `(ftime, fstatus)`: $(X, \delta)$; `cov1`: $Z$
    -   `failcode = k`: models $k$th risk
:::
:::{.fragment}
-   **Output**: a list of class `crr`
    -   `obj$coef`: $\hat\beta_k$; `obj$var`: $\hat\var(\hat\beta_k)$
    -   `obj$uftime`: $t$; `obj$bfitj`: $\dd\hat\Lambda_{k0}(t)$
:::

## Software: `cmprk::crr()` (II)
:::{.fragment}
-   **Prediction of CIF by Fine-Gray model**
    -   `obj`: a `crr` object for fit model
    -   `z`: new covariate data
:::
:::{.fragment}

::: big-code
```{r}
#| eval: false
#| echo: true
#| code-line-numbers: 1-2|4-11
# --- Method 1: use predict.crr() 
obj_pred <- predict(obj, z)

# --- Method 2: manual calculation
beta <- obj$coef
Lambda <- cumsum(obj$bfitj)
time <- obj$uftime
## Calculate CIF based on FG model
cif <- 1- exp(- exp(sum(beta * z)) * Lambda)
## Same as obj_pred from Method 1
obj_pred <- cbind(time, cif)
```
:::
:::

## Software: `tidycmprk` Package (I)
:::{.fragment}
-   **Tidy competing risks analysis**
    -   Wraps around `cmprk` functions
    -   Formula-based interface $+$ Tidy output
    -   Integrated with `ggsurvfit` and `gtsummary`
-   **Main functions**
    -   **Nonparametric analysis**
        -   `tidycmprsk::cuminc()`: model fitting
        -   `tidycmprsk::tbl_cuminc()`: tabulation of CIF estimates
        -   `ggsurvfit::ggcuminc()`: plotting of CIF estimates
    -   **Fine-Gray regression**
        -   `tidycmprsk::crr()`: model fitting
        -   `gtsummary::tbl_regression()`: regression table
:::

## Software: `tidycmprk` Package (II)
:::{.fragment}
-   **Sample code**
```{r}
#| eval: false
#| echo: true
#| code-line-numbers: 1-2|3-8|9-10|12-13|15-16
# Compute and test on cumulative incidence function (CIF) -------------------
obj_cif <- tidycmprsk::cuminc(Surv(time, status) ~ group, data = df)
# Tabulate CIF estimates with 95% CI at specific times
tbl_surv <- tidycmprsk::tbl_cuminc(
    x = obj_cif,                     # Provide fitted object
    times = seq(12, 120, by = 36),   # Time points for CIF
    outcomes = c("1", "2"),          # Specify risks to include
) 
# Create group-specific CIF plot
ggcuminc(obj_cif, outcome = c("1", "2"))  # Specify risks to include

# Fine-Gray regression for risk "k" -----------------------------------------
obj_fg <- tidycmprsk::crr(Surv(time, status) ~ covariates, 
                           data = df, failcode = "k")
# Tabulate regression results
tbl <- tbl_regression(obj_fg, exponentiate = TRUE)
```
:::


# Bone Marrow Transplant Study

## Study Information

:::{.fragment}
-   **Population** 
    -   864 multiple-myeloma patients undergoing allo-HCT cell transplantation
-   **Endpoints**: time from surgery to
    -  **Treatment-related mortality** (TRM; death in remission)
    -   **Relapse of leukemia**
-   **Risk factors**
    -   Cohort indicator (years 1995–2000 or 2001–2005)
    -   Type of donor (unrelated or HLA-identical sibling)
    -   History of a prior transplant
    -   Time from diagnosis to transplantation (\<24 months, or ≥ 24 months)
:::

## Study Data
:::{.fragment}
-   **Data format**

```{r}
#| eval: false
#| echo: true
head(cibmtr)
#>    time status cohort donor hist wait
#> 1 0.010      2      1     1    1    1
#> 2 0.066      2      1     1    1    0
#> 3 0.099      1      1     1    1    1
#> ...
```

![](images/cmpr_cibmtr.png){fig-align="center" width="75%"}
:::

## CIF by Donor Type (I)
:::{.fragment}
-   **Estimation/testing by donor type**

```{r}
#| eval: false
#| echo: true
#| code-line-numbers: 1-7|9-16
obj_cif <- tidycmprsk::cuminc(Surv(time, status) ~ donor, data = df)
obj_cif # Print results
#> ...
#> • Tests
#> outcome   statistic   df     p.value    
#> Relapse   17.3        1.00   <0.001     
#> TRM       12.3        1.00   <0.001

# Summarize CIF estimates at specific times 
tbl_surv <- tbl_cuminc(
    x = obj_cif,                     # Provide the fitted object
    times = seq(12, 120, by = 36),   # Time points for CIF
    outcomes = c("Relapse", "TRM"),  # Specify risks to include
    label_header = "{time} months"   # Column label format
) 
tbl_surv
```
:::



## CIF by Donor Type (II)
:::{.fragment}
-   **Table created by `tbl_cuminc()`**

![](images/cmpr_bm_cif_tbl.png){fig-align="center" width="90%"}
:::


## CIF by Donor Type (III)
:::{.fragment}
-   **Graphics**
```{r}
#| eval: false
#| echo: true
obj_cif |> ggcuminc(outcome = c("Relapse", "TRM")) # + ggplot2 formatting
```
:::
:::{.fragment}
![](images/cmpr_bm_cif.png){fig-align="center" width="70%"}
:::

## Regression Analysis
:::{.fragment}
-   Semiparametric regression
    -   Proportional cause-specific hazard
    -   Proportional sub-distribution hazard (FG)

```{r}
#| eval: false
#| echo: true
# Change k
k <- 1
#--- proportional cause-specific hazards -----------------------------
obj.cs <- coxph(Surv(time, status == k) ~ cohort + donor + hist + wait,
                data = cibmtr)

#--- Fine and Gray --------------------------------------------------
obj.fg <- crr(cibmtr$time, cibmtr$status, cibmtr[, 3:6], failcode = k)

```
:::

## Regression Results
:::{.fragment}
-   **Differential effects of prior surgery**
    -   **Relapse**: increases risk by $42\%$
    -   **TRM**: decreases risk by $1-0.63 = 37\%$ ![](images/cmpr_bm_reg.png){fig-align="center" width="80%"}
:::

# Semi-Competing Risks

## Definition and Examples
:::{.fragment}
-   **Semi-competing risks**
    -   **Terminal event** (competing): death
    -   **Non-terminal events** (non-competing): hospitalization, relapse, etc.
:::
:::{.fragment}
-   **Examples**
    -   Death + relapse of cancer (German breast cancer study)
    -   Death terminates nonfatal event but not *vice versa*
:::
:::{.fragment}
-   **Methods**
    -   **Marginal**: cumulative incidence/frequency
    -   **Frailty** (Ch. 8); **Multistate** (Ch. 12); **Composite** (Ch. 13)
:::

## Data and Identifiability

::::: columns
:::{.fragment}
::: {.column width="55%"}
-   **Target of inference**: $(T, D)$
    -   $T$: time to nonfatal event
    -   $D$: time to death
    -   **Joint distribution** $$H(s, t)=\pr(D>s, T>t)$$
    -   **Identifiable region**: $\{(s, t):0\leq t\leq s<\infty\}$
        -   Possible nonfatal $\to$ death, not *vice versa*
:::
::: {.column width="45%"}

![](images/cmpr_wedge.png){fig-align="center" width="100%"}
:::
:::
:::::

## Bivariate Analysis
:::{.fragment}
-   **Marginal models**
    -   **Death**: univariate event (KM, log-rank, Cox)
    -   **Nonfatal event**
        -   Cause-specific risk (treating death as censoring)
        -   cumulative incidence (Gray, FG)
:::
:::{.fragment}
-   **German breast cancer study**
    -   **Nonfatal event**: relapse of cancer (`status == 1`)
    -   **Death**: overall mortality (`status == 2`)

```{r}
#| eval: false
#| echo: true
gbc <- read.table("Data//German Breast Cancer Study//gbc.txt") |>
   mutate(age40 = (age > 40) + 0) # create age40: I(age > 40)
```
:::


## Bivariate Analysis - GBC Example (I)
:::{.fragment}
-   **Data**
```{r}
#| eval: false
#| echo: true
gbc
#    id      time status hormone age meno size grade nodes prog estrg age40
# 1   1 43.836066      1       1  38    1   18     3     5 1.41  1.05     0
# 2   1 74.819672      0       1  38    1   18     3     5 1.41  1.05     0
# 5   3 41.934426      1       1  47    1   30     2     1 4.22  0.89     1
# 6   3 47.737705      2       1  47    1   30     2     1 4.22  0.89     1
```
:::
:::{.fragment}
-   **Analysis**
    -   **Death** (subset to `status != 1`)
        -  Standard Cox: `coxph(Surv(time, status == 2) ~ covariates)`
    -   **Relapse** (subset to first row for each `id`)
        -  Cause-specific hazard: `coxph(Surv(time, status == 1) ~ covariates)`
        -  Sub-distribution hazard: `tidycmprk::crr(Surv(time, status) ~ covariates, failcode = "1")`
:::

## Bivariate Analysis - GBC Example (II)
:::{.fragment}
-   **Regression results**
    -   **Relapse**: cause-specific $\approx$ sub-distribution---few deaths (21) before relapse
    -   **Age effect**: driven by relapse
![](images/cmpr_gbc_reg.png){fig-align="center" width="75%"}
:::

  
## Recurrent Events
:::{.fragment}
-   **Outcome data**: $\{N^*(\cdot), D\}$
    -   $N^*(t)$: number of recurrent events in presence of death
        -   Repeated tumor occurrences/hospitalizations before death ($\dd N^*(t)\equiv 0$ for $t>D$)
    -   Treating $D$ as censoring (AG/LWYY) $\to$ cause-specific event rate $$E\{\dd N^*(t)\mid D\geq t\}$$
        -   Incidence rate in survivors
:::
:::{.fragment}
-   **Cumulative frequency**
    -   Mean function in overall population, dead or alive $$
        \mu(t)=E\{N^*(t)\}
        $$
    -   Extension of cumulative incidence
:::

## Marginal Approaches
:::{.fragment}
-   **Methods for cumulative frequency**
    -   Gray-type nonparametric estimator/test (Ghosh and Lin, 2000)
    -   Proportional CF model (Fine-Gray-type) (Ghosh and Lin, 2002) \begin{equation}\label{eq:cmpr:pcf}
        E\{N^*(t)\mid Z\}=\exp(\beta^\T Z)\mu_0(t)
        \end{equation}
    -   Higher death rate can reduce CF
:::
:::{.fragment}
-   **Joint analysis with mortality**
    -   Ghosh-Lin for recurrent events $+$ Cox/log-rank for death
    -   $\chi^2$ test with 2 d.f.
:::
:::{.fragment}
-   **Alternative:** shared-frailty models
:::

## Software: `rccf2::rccf()` 
:::{.fragment}
-   **Two-sample estimation/testing of CF**

::: big-code
```{r}
#| eval: false
#| echo: true
devtools::install_github("lmaowisc/rccf2")
library(rccf2) # Load package
obj <- rccf(id, time, status, trt) # Fit model
```
:::

-   **Input**
    -   `id`: subject ID; `trt`: binary treatment group
    -   `time`: event time; `status`: event status (1: nonfatal; 2: death; 0: censoring)
:::    
:::{.fragment}
-   **Output**
    -   `obj$u1`, `obj$u2`: Estimates of group-specific 
          $\mu(t)$ as a function of $t$ (`obj$t`).
    -   `obj$pLR`, `obj$pD`, `obj$pjnt`: $p$-values for tests on $\mu(t)$, death, and jointly
:::

## Example: Bladder Tumor Study (I)
:::{.fragment}
-   **Bladder cancer trial** (Byar, 1980)
    -   **Treatment groups**: thiotepa ($n=38$) vs placebo ($n=48$)
    -   **Endpoints**: tumor recurrences and death 
   ![](images/cmpr_bladder_df.png){fig-align="center" width="70%"}
:::

## Example: Bladder Tumor Study (II)   
:::{.fragment}    
-   **Survival and cumulative frequency**
    -   Joint $\chi_2^2$ test: $p$-value 0.184
    ![](images/cmpr_bladder.png){fig-align="center" width="70%"}
:::

# Conclusion

## Notes

-   **Fine--Gray regression**
    -   **Model diagnostics**: R package `crskdiag` 
    -   **Proportional sub-distribution odds model** (Eriksson et al., 2015)
    ```{r}
    #| eval: false
    #| echo: true
    library(timereg)
    # Fit a proportional sub-distribution odds model for the kth risk
    obj_po <- prop.odds.subdist(Event(time, status) ˜ covariates, cause = k)
    ```
    -   **Interval-censored competing risks**  (Mao et al., 2018)

-   **Semi-competing risks**
    -   Term coined by Fine, Jiang, and Chappell (2001)
    -   Multivariate (here), multistate (Chapter 12), and composite (Chapter 13)
    -   Nonfatal event as *mediator* of treatment effect on death (Huang, 2021, 2022) 

## Summary

-   **Competing risks**
    -   **Cause-specific hazard**: conditional failure rate on survivors
        -   `coxph(Surv(time, status == k) ~ covariates)`
    -   **Cumulative incidence**: marginal failure probability under other risks
        -   **Gray's estimator/test** `cmprk::cuminc(ftime, fstatus, group, strata, rho = 0)`
        -   **Fine-Gray model** `cmprk::crr(ftime, fstatus, cov1, failcode = k)`
        -   **Tidy tables and graphics**: `tidycmprk` package

-   **Recurrent events in presence of death**
    -   **Ghosh-Lin methods**
        -   **Nonparametric**: `rccf2::rccf(id, time, status, trt)`
        -   **Proportional CF model**: R packages `mets` and `reReg`
        
        
        
        